A novel bioinformatic method for the identification of antimicrobial peptides in metagenomes

Julianne Megaw,Timofey Skvortsov,Giulia Gori,Aliyu I Dabai,Brendan F Gilmore,Christopher C R Allen
DOI: https://doi.org/10.1093/jambio/lxae045
2024-02-21
Journal of Applied Microbiology
Abstract:Abstract Aims This study aimed to develop a new bioinformatic approach for the identification of novel antimicrobial peptides (AMPs), which did not depend on sequence similarity to known AMPs held within databases, but on structural mimicry of another antimicrobial compound, in this case an ultrashort, synthetic, cationic lipopeptide (C12-OOWW-NH2). Methods and Results When applied to a collection of metagenomic datasets, our outlined bioinformatic method successfully identified several short (8–10aa) functional AMPs, the activity of which was verified via disk diffusion and minimum inhibitory concentration (MIC) assays against a panel of 12 bacterial strains. Some peptides had activity comparable to, or in some cases greater than those from published studies that identified AMPs using more conventional methods. We also explored the effects of modifications, including extension of the peptides, observing an activity peak at 9–12aa. Additionally, the inclusion of a C-terminal amide enhanced activity in most cases. Our most promising candidate (named PB2-10aa-NH2) was thermally stable, lipid soluble, and possessed synergistic activity with ethanol, but not with a conventional antibiotic (streptomycin). Conclusions While several bioinformatic methods exist to predict AMPs, the approach outlined here is much simpler and can be used to quickly scan huge datasets. Searching for peptide sequences bearing structural similarity to other antimicrobial compounds may present a further opportunity to identify novel AMPs with clinical relevance, and provide a meaningful contribution to the pressing global issue of AMR.
microbiology,biotechnology & applied microbiology
What problem does this paper attempt to address?
The main objective of this paper is to develop a new bioinformatics method to identify novel antimicrobial peptides (AMPs) in metagenomic data. This method does not rely on similarity to known AMP sequences in existing databases but is based on structural modeling of another antimicrobial compound (in this case, an ultra-short synthetic cationic lipopeptide C12-OOWW-NH2). Specifically, the research team achieved this goal through the following steps: 1. **Data Collection**: 66 soil samples were collected from geographically diverse locations, and microbial DNA was extracted from them for sequencing. 2. **Metagenomic Assembly and Prediction**: Metagenomic assembly was performed for each sample, and protein-coding genes were predicted. 3. **Peptide Identification and Synthesis**: Python scripts were written to search for peptide sequences that fit specific patterns, with structural features similar to the synthetic lipopeptide. 12 peptides were selected for synthesis and activity testing. 4. **Activity Testing**: The selected peptides were tested for antimicrobial activity, including diffusion disk method and minimum inhibitory concentration (MIC) determination. 5. **Structural Optimization**: Peptides that showed activity underwent structural modifications such as extension, inversion, and terminal modifications to further enhance their antimicrobial performance. The research results indicate that this method can successfully identify short peptides (8-10 amino acids) with antimicrobial activity from metagenomic data. In particular, the PB2-10aa-NH2 peptide exhibited good antimicrobial activity and showed potential application value in terms of thermal stability and synergy with other antimicrobial agents. This provides a new and efficient approach for discovering novel antimicrobial peptides, helping to address the increasingly serious issue of antibiotic resistance.